slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,369
Current window 31,051-31,080
Pages 1,379
Rows per page 30
Component
31,051-31,080 of 41,369
03
The slide uses a bulleted list to summarize clinical trial milestones and data-driven decision-making.Athira Pharma | Results Presentation Deck | 11 slides · Athira Pharma
Conference presentation Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
07
The slide uses a list format to show progress/process steps.Athira Pharma | Results Presentation Deck | 11 slides · Athira Pharma
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
11
The slide uses a grid of metrics to establish the market size and the problem (lack of new treatments).Athira Pharma | Results Presentation Deck | 11 slides · Athira Pharma
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
09
Includes a scientific diagram of the GABAa receptor complex.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank Beat · Solution1 hit
10
The table uses checkmarks to indicate the strength of effect for different GABA-A subtypes (alpha 1, 2, 3, 5).Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank Beat · Solution1 hit
14
The slide uses a hexagonal layout to present five key product attributes.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank Beat · Market SizeLoop · Cost Of Inaction1 hit
15
The slide notes that BAER-101 was previously known as AZD7325.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank Beat · Product1 hit
16
The slide highlights the therapeutic window of BAER-101 by showing efficacy in the punished model without significant impairment in the un-punished model.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank Beat · Product1 hit
18
The chart shows BAER-101 regimens consistently resulting in lower sleepiness rates than Lorazepam.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank 1 hit
19
Includes a medical warning regarding photosensitivity.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank 1 hit
22
The slide uses a hub-and-spoke style diagram to illustrate the dual mechanism.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank 1 hit
24
Avenue Therapeutics | IPO Presentation Deck | 30 slidesAvenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank 1 hit
05
The slide uses a combination of area charts to visualize delinquency volumes over time, with a callout box summarizing key performance drivers and metrics.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
25
The slide uses a structured layout to present key performance indicators across three thematic pillars.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI Overview1 hit
31
The slide uses a table to demonstrate long-term strategic shifts in loan portfolio composition and capital adequacy.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · Appendix Data1 hit
14
The slide uses a split-layout with a dark sidebar for partnership specifics and a light main area for strategic benefits.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
19
The slide contrasts the market problem (left) with the proposed solution/mechanism (right).BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
21
Includes a breakdown of UC patient severity segments (64%, 31%, 5%).BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
22
The slide uses a process diagram to explain the experimental setup (biopsy -> organ culture -> measurement) followed by bar charts showing efficacy.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
34
The slide uses a process flow diagram to illustrate data ingestion, NLP-based extraction, and the resulting knowledge graph.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
39
The slide uses a flowchart to illustrate the adaptive clinical trial design.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
46
The slide uses a comparison table to contrast the drug's mechanism of action against competitors and highlights safety concerns with current standards of care.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
05
Speed Bump cartoon by Dave Coverly, 2011.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Problem1 hit
06
The slide uses a yellow callout box to provide context for the quote.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
17
The slide illustrates the 'Approach' side of the conflict; the 'Avoidance' side is implied by the context of SAD.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
50
The slide uses a process flow diagram to illustrate the clinical trial methodology.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
07
The slide presents experimental data from a study on live-attenuated pneumococcal vaccines.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
03
Includes non-GAAP adjustments for notable items.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Financial HighlightsLoop · Cost Of Inaction1 hit
05
The slide uses a timeline-based process diagram to explain the clinical trial structure.BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · AgitateLoop · Before After1 hit
09
The slide uses a central hub-and-spoke style diagram to connect pillars to ambitions, with a footer emphasizing safety as a non-negotiable value.Braskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · ComplicationLoop · Cost Of Inaction1 hit